PV Bulletin

MHRA Regulatory Reform Amendments Tabled in Government’s Health Bill

Proposed amendments to support information sharing, regulatory reform and the future development of a medical device licensing regime.

Primary source: Open Government Licence v3.0

PV Impact Brief

MonitoringConfidence: high

What changed

The amendments propose clearer legal powers for MHRA to share information regarding medicines and devices, automatic updates to legislation reflecting advances in science, and future enabling powers for a medical device licensing regime.

Why it matters

The proposed changes could significantly impact the regulation of medicines and medical devices, ensuring a more responsive and efficient regulatory environment that aligns with advancements in healthcare technology.

Action needed

Organizations involved in medical device compliance should prepare for potential future changes requiring MHRA-issued licenses for devices entering the market.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Country Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 1, 2026

Full briefing

Practical implication

Organizations involved in medical device compliance should prepare for potential future changes requiring MHRA-issued licenses for devices entering the market.

The MHRA has proposed amendments to the Health Bill aimed at modernizing the UK regulatory framework for medicines and medical devices. Key areas of focus include clearer information sharing powers, updates to regulatory legislation, and future medical device licensing capabilities.

What changed: The amendments propose clearer legal powers for MHRA to share information regarding medicines and devices, automatic updates to legislation reflecting advances in science, and future enabling powers for a medical device licensing regime.

Why it matters: The proposed changes could significantly impact the regulation of medicines and medical devices, ensuring a more responsive and efficient regulatory environment that aligns with advancements in healthcare technology.

Practical implication: Organizations involved in medical device compliance should prepare for potential future changes requiring MHRA-issued licenses for devices entering the market.

View original source

  • Source: MHRA - News and communications
  • Published at source: 2026-09-01T00:00:00.000Z
  • Discovered by monitor: 2026-09-01T22:03:08.147Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Regulatory Intelligence#Guidance#Source-ingestion#Regulator-monitor#Uk#Gov.uk

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Urgent Withdrawal of Reusable da Vinci S and Si Instruments Due to Cable Degradation

Urgency: High

Healthcare facilities must isolate the affected instruments and notify Intuitive Surgical for returns while preparing for potential delays in surgical procedures due to instrument replacements.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Latest
Read impact briefarrow_forward